cResponse

CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, has signed an exclusive distribution agreement with Curesponse Ltd, to market the cResponse™ cancer assay in…